National Cancer Institute; Amended Notice of Meeting, 22500 [2018-10352]
Download as PDF
<![CDATA[
daltland on DSKBBV9HB2PROD with NOTICES
22500
Federal Register / Vol. 83, No. 94 / Tuesday, May 15, 2018 / Notices
comments on the agenda topics.
Guidelines for public comments are
available at https://ntp.niehs.nih.gov/
ntp/about_ntp/guidelines_public_
comments_508.pdf.
The deadline for submission of
written comments is June 12, 2018.
Written public comments should be
submitted through the meeting website.
Persons submitting written comments
should include name, affiliation,
mailing address, phone, email, and
sponsoring organization (if any). Written
comments received in response to this
notice will be posted on the NTP
website, and the submitter will be
identified by name, affiliation, and
sponsoring organization (if any).
Oral Public Comment Registration:
The agenda allows for three public
comment periods: The first comment
period on the strategic realignment (6
commenters, up to 5 minutes per
speaker); the second comment period on
the peer review of NTP’s studies of cell
phone radiofrequency radiation (6
commenters, up to 5 minutes per
speaker); and the third comment period
on the CLARITY–BPA Research
Program: Peer Review of Core Study and
Next Steps (6 commenters, up to 5
minutes per speaker). Oral comments
may be presented in person at NIEHS or
by teleconference line. Registration for
oral comments is on or before June 12,
2018, at https://ntp.niehs.nih.gov/go/165.
Registration is on a first-come, firstserved basis, and registrants will be
assigned a number in their confirmation
email. Each organization is allowed one
time slot per comment period. After the
maximum number of speakers per
comment period is exceeded,
individuals registered to provide oral
comment will be placed on a wait list
and notified should an opening become
available. Commenters will be notified
after June 12, 2018, about the actual
time allotted per speaker, and the
teleconference number will be sent to
those registered to give oral comments
by teleconference line.
If possible, oral public commenters
should send a copy of their slides and/
or statement or talking points to Robbin
Guy by email: guyr2@niehs.nih.gov by
June 12, 2018.
Meeting Materials: The preliminary
meeting agenda is available on the
meeting web page (https://
ntp.niehs.nih.gov/go/165) and will be
updated one week before the meeting.
Individuals are encouraged to access the
meeting web page to stay abreast of the
most current information regarding the
meeting.
Background Information on the BSC:
The BSC is a technical advisory body
comprised of scientists from the public
VerDate Sep<11>2014
20:27 May 14, 2018
Jkt 244001
and private sectors that provides
primary scientific oversight to the NTP.
Specifically, the BSC advises the NTP
on matters of scientific program content,
both present and future, and conducts
periodic review of the program for the
purpose of determining and advising on
the scientific merit of its activities and
their overall scientific quality. Its
members are selected from recognized
authorities knowledgeable in fields such
as toxicology, pharmacology, pathology,
biochemistry, epidemiology, risk
assessment, carcinogenesis,
mutagenesis, molecular biology,
behavioral toxicology, neurotoxicology,
immunotoxicology, reproductive
toxicology or teratology, and
biostatistics. Members serve overlapping
terms of up to four years. The BSC
usually meets biannually. The authority
for the BSC is provided by 42 U.S.C.
217a, section 222 of the Public Health
Service Act (PHS), as amended.
The BSC is governed by the
provisions of the Federal Advisory
Committee Act, as amended (5 U.S.C.
app.), which sets forth standards for the
formation and use of advisory
committees.
Dated: May 9, 2018.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
[FR Doc. 2018–10359 Filed 5–14–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Cancer
Institute Special Emphasis Panel, June
11, 2018, 01:00 p.m. to June 11, 2018,
03:00 p.m., National Cancer Institute
Shady Grove, 9609 Medical Center
Drive, 7W618, Rockville, MD 20850
which was published in the Federal
Register on May 04, 2018, 83 FR 19789.
This meeting notice is amended to
change the meeting date from June 11,
2018 to June 13, 2018. The meeting time
has changed from 1:00 p.m.–3:00 p.m. to
10:30 a.m.–12:30 p.m. The meeting is
closed to the public.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; NIGMS Postdoctoral T32 Training
Grant Applications.
Date: July 10, 2018.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Room 3AN18, 45 Center
Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian R. Pike, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892, 301–594–3907, pikebr@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: May 10, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–10355 Filed 5–14–18; 8:45 am]
BILLING CODE 4140–01–P
Dated: May 10, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–10352 Filed 5–14–18; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00060
Fmt 4703
Sfmt 9990
E:\FR\FM\15MYN1.SGM
15MYN1
]]>Agencies
[Federal Register Volume 83, Number 94 (Tuesday, May 15, 2018)]
[Notices]
[Page 22500]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-10352]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Cancer Institute Special Emphasis Panel, June 11, 2018, 01:00 p.m. to
June 11, 2018, 03:00 p.m., National Cancer Institute Shady Grove, 9609
Medical Center Drive, 7W618, Rockville, MD 20850 which was published in
the Federal Register on May 04, 2018, 83 FR 19789.
This meeting notice is amended to change the meeting date from June
11, 2018 to June 13, 2018. The meeting time has changed from 1:00 p.m.-
3:00 p.m. to 10:30 a.m.-12:30 p.m. The meeting is closed to the public.
Dated: May 10, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-10352 Filed 5-14-18; 8:45 am]
BILLING CODE 4140-01-P
